Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 31-40 of 204 for Amyloidosis

Edit search filters
  1. A Study To Evaluate The Effectiveness And Safety Of CAEL-101 In Patients With Mayo Stage IIIa AL Amyloidosis

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  2. A Study Using Magnetic Resonance Elastography to Assess Heart Muscle Stiffness in Patients with Cardiac Amyloidosis

    Rochester, MN

  3. A Study to Assess the Long-Term Safety and Efficacy of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Patients With Hereditary Transthyretin-Mediated Amyloid Polyneuropathy

    Scottsdale/Phoenix, AZ

  4. Open-Label Extension Assessing Long Term Safety and Efficacy of ISIS-TTR Rx in Familial Amyloid Polyneuropathy (FAP)

    Rochester, MN

  5. Efficacy and Safety of ISIS-TTR Rx in Familial Amyloid Polyneuropathy

    Rochester, MN

  6. Study Of AG10 In Amyloid Cardiomyopathy

    Rochester, MN

  7. A Research Study To Look At How A New Medicine Called NNC6019-0001 Works And How Safe It Is For People Who Have Heart Disease Due To Transthyretin (TTR) Amyloidosis

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  8. ATTR Expanded Access Program (EAP) by Ionis

    Rochester, MN

  9. A Study of the Safety and Effectiveness of NEOD001 for Treating Previously Treated Patients with Persistent Cardiac Dysfunction Related to Light Chain Amyloidosis

    Jacksonville, FL, Rochester, MN

  10. Study and Safety Monitoring of Patients with Symptomatic Transthyretin Cardiomyopathy Who Have Completed the Phase II Study AG10-201

    Rochester, MN

.

Mayo Clinic Footer